COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Tome Biosciences develops programmable genomic integration using integrase‑mediated PASTE combining CRISPR/Cas9 targeting with integrases to insert large (>30 kb) DNA without double‑strand breaks for gene and cell therapies.
